Last reviewed · How we verify
Skin Prick Test - Non Atopic subjects — Competitive Intelligence Brief
phase 2
Biologic
Live · refreshed every 30 min
Target snapshot
Skin Prick Test - Non Atopic subjects (Skin Prick Test - Non Atopic subjects) — Roxall Medicina España S.A.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Skin Prick Test - Non Atopic subjects TARGET | Skin Prick Test - Non Atopic subjects | Roxall Medicina España S.A | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Skin Prick Test - Non Atopic subjects CI watch — RSS
- Skin Prick Test - Non Atopic subjects CI watch — Atom
- Skin Prick Test - Non Atopic subjects CI watch — JSON
- Skin Prick Test - Non Atopic subjects alone — RSS
Cite this brief
Drug Landscape (2026). Skin Prick Test - Non Atopic subjects — Competitive Intelligence Brief. https://druglandscape.com/ci/skin-prick-test-non-atopic-subjects. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab